Literature DB >> 28025076

Unusual extramedullary hematopoietic neoplasms in lymph nodes.

Vanessa D Dayton1, Sarah J Williams2, Robert W McKenna2, Michael A Linden2.   

Abstract

Myeloid, plasma cell, and lymphoblastic neoplasms are expected findings in bone marrow but are much less commonly diagnosed as primary processes in lymph nodes. The objective of this review is to aid pathologists in recognizing common hematopoietic neoplasms in the unusual setting of initial presentation in lymph nodes. Review of historical background and evolution of testing strategies is presented to improve understanding of the need for accurate diagnosis and classification using current nomenclature. The review is based on peer-reviewed literature and the personal experience of the authors. The University of Minnesota Medical Center, Fairview provides lymph node diagnostic consultation services for its busy oncology and therapeutic hematopoietic cell transplant divisions serving patients from around the globe. Although readily recognizable when they present in bone marrow, myeloid leukemia in the form of myeloid sarcoma, plasmacytoma, and lymphoblastic lymphoma can create diagnostic and classification challenges when they present as primary lymph node pathologies. Use of all diagnostic tools may be necessary to ensure accurate and reproducible diagnoses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Lymphoblastic leukemia; Lymphoblastic lymphoma; Multiple myeloma; Myeloid sarcoma; Plasmacytoma

Mesh:

Substances:

Year:  2016        PMID: 28025076     DOI: 10.1016/j.humpath.2016.12.014

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Solitary Plasmacytoma of the Mesentery: A Systematic Clinician's Diagnosis.

Authors:  Georgia Mitropoulou; Adamantia Zizi-Sermpetzoglou; Hippokrates Moschouris; Athanasios Kountourogiannis; Despoina Myoteri; Dionysios Dellaportas
Journal:  Case Rep Oncol Med       Date:  2017-05-11

2.  Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma.

Authors:  Nieves Gómez León; Beatriz Aguado Bueno; María Herreros Pérez; Luisa F León Ramírez; Adrián Alegre; Patrick M Colletti; Domenico Rubello; José L Carreras; Roberto C Delgado Bolton
Journal:  Clin Nucl Med       Date:  2021-04-01       Impact factor: 10.782

3.  Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: A SEER-based study.

Authors:  Ziping Xing; Xiaohua Zhu; Zifeng Li; Hongsheng Wang; Maoxiang Qian; Xiaowen Zhai
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.